Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014


Discovery Chemistry Congress

18 Feb 2014 - 19 Feb 2014 - Barcelona, Spain



Bookmark and Share


This conference will integrate the latest structural chemistry with innovative discovery-driven technologies. Speakers will concentrate on the most important aspects of discovery stages for effective drug design and refinement. In the current economic climate there is increasing global competitiveness and financial pressure, therefore this conference aims to explore the options available to maximise the success of drug discovery and development.  

Dr. Mark Bradley (Professor, University of Edinburgh) will be serving as the Conference Chair for Discovery Chemistry Congress. Our collaboration with Dr. Bradley will ensure this conference will integrate the latest options available to maximise the success of drug discovery and development. Planned round table discussions on key areas are sure to energize the participants in defining the drug discovery and development landscape. Open to all conference and exhibition attendees, these discussions will provide an excellent opportunity to exchange ideas and network.  

Ultimately, this conference will overcome the challenges of drug delivery in a completely new way. SELECTBIO hopes to help delegates convert this expensive, challenging and inefficient process into a more accessible and affordable one. This conference will provide an excellent platform for researchers from all areas of drug discovery research to discuss the future perspectives and collaborative options amongst various research departments.

Reasons to attend:
•    Exchange ideas and expand your network with leading professionals in this field
•    This conference will bring together top international scientists and clinicians presenting cutting-edge discoveries
•    Up-to-date research in the fields of optical imaging and stem cell chemistry
•    The conference will feature an extensive exhibition and poster session
•    Round table discussions open to all attendees will engage networking and discussion

The conference will be co-located with Flow Chemistry Europe and ADME & Predictive Toxicology. Registered delegates will have unrestricted access to all co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees. Running alongside the Discovery Chemistry Congress will be an exhibition covering the latest technological advances and associated services within these fields. 

The Agenda is now online.







Further information
Scientific News
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
Crystals, Super Magnets in Drug Discovery
Scientists have produced larger superparamagnetic crystals that could revolutionise drug delivery.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Snapshots of Chemical Flipping a Biological Switch
X-ray laser gets first real-time snapshots of a chemical flipping a biological switch, opening new path to understanding how RNA works.
Uncovering Elusive Proteins
Researchers have determined the complete structure of elusive proteins, known as tetraspanins, for the first time.
Cannabinoid Receptor Structure Revealed
Scientists provided a detailed view of the primary molecule through which cannabinoids exert their effects on the brain. The findings might help guide the design of more targeted medicines with fewer side effects.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Study Unocovers Cancer-Linked Protein’s Associates
Researchers have developed a new list of nearly 100 potential partners of a cancer-linked enzyme by studying its interactions with other proteins.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!